The revenue slipped marginally during the September 2024 quarter. A decline of about Rs. 403.23 millions was observed as compared to Rs. 406.78 millions during the corresponding quarter last year.The Company has registered profit of Rs. 26.16  millions for the quarter ended September 2024, a growth of 5.31%  over Rs. 24.84 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2024 rose to 48.14 millions as compared to 41.63 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 403.23 406.78 -0.87 736.09 826.25 -10.91 1524.66 1153.50 32.18
Other Income 10.22 1.59 542.77 15.27 20.28 -24.70 35.22 32.73 7.61
PBIDT 48.14 41.63 15.64 65.31 123.26 -47.01 146.34 189.90 -22.94
Interest 6.23 4.38 42.24 12.74 10.39 22.62 22.90 20.38 12.37
PBDT 41.91 37.25 12.51 49.12 112.87 -56.48 123.44 169.52 -27.18
Depreciation 15.75 12.41 26.91 30.19 24.53 23.07 49.95 53.34 -6.36
PBT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 11.94 10.23 16.66 8.87 14.92 -40.52 9.60 16.46 -41.70

Bafna Pharma Share Price

164.20 -7.80 (-4.53%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×